** Carl Zeiss Meditec AG's AFXG.DE shares slip around 2% in early Frankfurt trade
** J.P.Morgan places the German optical systems maker on negative catalyst watch into Q2 results on May 14, sticking to its "underweight" rating
** The broker notes the stock rising 35% YTD, adding it struggles to justify the move as the firm sits in the bottom quartile for earnings growth and upper quartile for valuation
** It also highlights the firm's continued underperformance over the past two years and fears market share losses in China and the U.S.
** Carl Zeiss Meditec falls to the bottom of Germany's midcaps index .MDAXI
(Reporting by Tristan Veyet)
((Tristan.chabba@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。